查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1424065

支原体检测市场、份额、规模、趋势、产业分析报告：按产品/服务、技术、应用、最终用户、地区、细分市场预测，2024-2032

Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球支原体检测市场规模将达到290,964万美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

支原体是一种没有细胞壁的细菌。 它最有可能感染人体的呼吸、泌尿和生殖器官。 严格的法规和日益增长的消费者安全担忧正促使製药公司专注于全面的生物检测，包括支原体检测。

2023 年《微生物学杂誌》上发表的一项研究重点在于探讨生殖支原体检测的进展。 随着美国食品和药物管理局 (FDA) 最近批准基于分子的检测，诊断测试已在美国广泛采用，并且不再仅在少数实验室中提供。 这对支原体市场的成长有正面影响。

抗菌药物抗药性的出现使得检测药物和服务中是否存在支原体变得困难，从而刺激了确定抗药性的诊断测试的发展。 支原体主要在生物製药的生产过程中从研究到临床开发过程中检测到，这凸显了支原体检测的必要性，以确认特定疾病治疗的安全性和准确性。

推进该领域的研究创新和先进技术的采用预计将推动支原体检测市场的扩大。 例如，2023 年 11 月，QIAGEN 宣布推出三款新的 QIAcuity 试剂盒和软体更新，以扩展其在细胞和基因治疗、食品业和製药业的聚合□链反应技术的产品线。

生物製药公司为提高产品品质和安全性而不断扩张的努力正在对支原体检测市场产生积极影响。 例如，2023 年 11 月，专门从事保护药物免受细菌侵害的製药实验室 Bionique 宣布业务已扩展到纽约州克利尔湖。

支原体检测市场报告亮点

由于对现成测试试剂盒的需求，检测、试剂盒和试剂领域预计将在未来几年实现最高成长。

市场区隔领域由于能够提供快速测试结果而占据最大的市场份额。

由于生物製药产量的增加，细胞系测试部门预计将占据更大的收入份额。

由于细胞和基因治疗技术创新的不断发展，预计亚太地区将在预测期内实现最快的成长。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球支原体检测市场洞察

  • 支原体检测 - 产业概况
  • 支原体侦测市场动态
    • 促进因素和机会
      • 探索支原体检测的研究增加
      • 支原体相关健康问题的发生率增加
    • 抑制因素和挑战
      • 研究者抵制采用新创新
  • PESTLE分析
  • 支原体检测产业趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球支原体检测市场，依产品及服务划分

  • 主要发现
  • 简介
  • 检测、试剂盒及试剂
  • 设备
  • 服务

第 6 章全球支原体检测市场（依应用）

  • 主要发现
  • 简介
  • 细胞系测试
  • 病毒检查
  • 生产结束后的细胞检查

第 7 章全球支原体检测市场（依技术）

  • 主要发现
  • 简介
  • NAT
  • ELISA
  • 染色
  • 其他技术

第 8 章全球支原体检测市场（依最终用户）

  • 主要发现
  • 简介
  • 製药和生技公司
  • 细胞库和研究所
  • 合约研究组织
  • 学术研究所

第 9 章全球支原体检测市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年支原体检测市场评估（按地区）
  • 支原体检测市场－北美
    • 北美：支原体检测市场，按产品和服务划分，2019-2032 年
    • 北美：支原体检测市场，依最终用户划分，2019-2032 年
    • 北美：支原体检测市场，按应用划分，2019-2032 年
    • 北美：支原体检测市场，按技术，2019-2032 年
    • 支原体检测市场—美国
    • 支原体检测市场－加拿大
  • 支原体检测市场－欧洲
    • 欧洲：支原体检测市场，依产品与服务划分，2019-2032 年
    • 欧洲：支原体检测市场，依最终用户划分，2019-2032 年
    • 欧洲：支原体检测市场，依应用划分，2019-2032 年
    • 欧洲：支原体检测市场，按技术，2019-2032 年
    • 支原体检测市场 - 英国
    • 支原体检测市场 - 法国
    • 支原体检测市场 - 德国
    • 支原体检测市场 - 义大利
    • 支原体检测市场 - 西班牙
    • 支原体检测市场 - 荷兰
    • 支原体检测市场 - 俄罗斯
  • 支原体检测市场 - 亚太地区
    • 亚太地区：支原体检测市场，按产品和服务划分，2019-2032 年
    • 亚太地区：支原体检测市场，依最终用户划分，2019-2032 年
    • 亚太地区：支原体检测市场，依应用划分，2019-2032 年
    • 亚太地区：支原体检测市场，按技术，2019-2032 年
    • 支原体检测市场—中国
    • 支原体检测市场—印度
    • 支原体检测市场 - 日本
    • 支原体检测市场—马来西亚
    • 支原体检测市场 - 印尼
    • 支原体检测市场－韩国
  • 支原体检测市场 - 中东和非洲
    • 中东和非洲：支原体检测市场，按产品和服务划分，2019-2032 年
    • 中东和非洲：支原体检测市场，按最终用户划分，2019-2032 年
    • 中东和非洲：支原体检测市场，按应用划分，2019-2032 年
    • 中东和非洲：支原体检测市场，按技术，2019-2032 年
    • 支原体检测市场 - 沙乌地阿拉伯
    • 支原体检测市场—南非
    • 支原体检测市场 - 以色列
    • 支原体侦测市场－阿联酋
  • 支原体检测市场－拉丁美洲
    • 拉丁美洲：支原体检测市场，依产品与服务划分，2019-2032 年
    • 拉丁美洲：支原体检测市场，以最终用户划分，2019-2032 年
    • 拉丁美洲：支原体检测市场，按应用划分，2019-2032 年
    • 拉丁美洲：支原体检测市场，1按技术，2019-2032 年
    • 支原体检测市场 - 墨西哥
    • 支原体检测市场 - 巴西
    • 支原体检测市场－阿根廷

第 10 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 11 章公司简介

  • Agilent Technologies（US）
  • American Type Culture Collection（US）
  • Biological Industries Israel Beit Haemek Ltd.（Israel）
  • Bionique Testing Laboratories, Inc.（US）
  • Biotools B & M Labs, S.A.（Spain）
  • Charles River Laboratories International, Inc.（US）
  • Creative Bioarray（US）
  • Eurofins Scientific（Luxembourg）
  • GeneCopoeia, Inc.（US）
  • GenBio（Canada）
  • InvivoGen（US）
  • Lonza Group Ltd.（Switzerland）
  • Merck KGaA（Germany）
  • Meridian Bioscience, Inc.（US）
  • Minerva Biolabs GmbH（Germany）
Product Code: PM1785

The global mycoplasma testing market size is expected to reach USD 2909.64 Million by 2032, according to a new study by Polaris Market Research. The report "Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product & Service (Assays, Kits, & Reagents, Instruments, Services); By Technique; By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Mycoplasma is a type of bacteria without a cell wall. It is mostly likely to affect the respiratory, urinary, and genital tracts of humans. The presence of stringent regulations and growing concerns about consumer safety is enabling pharmaceutical companies to focus on comprehensive biological testing, including testing of mycoplasma.

A 2023 study published in the Journal of Microbiology focused on exploring advancements in the detection of Mycoplasma genitalium. The recent clearance of molecular-based assays by the U.S. Food and Drug Administration (FDA) permitted diagnostic testing to be widely employed in the United States, making it no longer available only in some laboratories. This is positively influencing the growth of the mycoplasma market.

The emergence of antimicrobial resistance made it difficult to test the presence of mycoplasma in pharmaceutical products and services, which fueled the development of diagnostic tests to determine resistance. Mycoplasma is mostly found in the production phase of biopharmaceutical products, including from the research stage to clinical development, highlighting the need for mycoplasma testing to check safety and accuracy in treating certain diseases.

The growing research innovations in this field and the adoption of advanced technologies are anticipated to promote the expansion of the mycoplasma testing market. For instance, in November 2023, QIAGEN unveiled its three new QIAcuity kits and software update to expand its product line for polymerase chain reaction technology in cell and gene therapies, the food industry, and the pharmaceutical industry.

Ongoing expansion activities by biopharmaceutical companies to enhance the quality and safety of their products are positively influencing the mycoplasma testing market. For instance, in November 2023, Bionique, a pharmaceutical lab specializing in protecting medicines from bacteria, expanded its location at Lake Clear, New York, to meet ongoing demand from rapidly growing cell and gene therapies in the region.

Mycoplasma Testing Market Report Highlights

Assays, Kits, & reagents segment is anticipated to witness the highest growth in the coming years due to the need for ready-to-test kits.

NAT segment accounted for the largest market share owing to its capability to offer faster results.

Cell line testing segment is projected to experience a larger revenue share due to growing biopharmaceutical production.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising innovations in cell and gene therapies.

The global players include Agilent Technologies, American Type Culture Collection, Biological Industries Israel Beit Haemek Ltd, & Bionique Testing Laboratories, Inc.

Polaris Market Research has segmented the mycoplasma testing market report based on product & service, technique, application, end user and region:

Mycoplasma Testing, Product & Service Outlook (Revenue - USD Million, 2019 - 2032)

  • Assays, Kits, & Reagents
  • NAT assays, kits, & reagents
  • ELISA assays, kits, & reagents
  • Elimination Kits
  • Stains
  • Other assays, kits, & reagents
  • Instruments
  • Services

Mycoplasma Testing, Technique Outlook (Revenue - USD Million, 2019 - 2032)

  • NAT
  • ELISA
  • Staining
  • Other technique

Mycoplasma Testing, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Cell line testing
  • Virus Testing
  • End-of-Production cell testing

Mycoplasma Testing, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Cell Banks & Laboratories
  • Contract Research Organizations
  • Academic Research Institutes

Mycoplasma Testing, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Mycoplasma Testing Market Insights

  • 4.1. Mycoplasma Testing - Industry Snapshot
  • 4.2. Mycoplasma Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising research studies exploring mycoplasma detection
      • 4.2.1.2. The growing incidence of mycoplasma-related health issues
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The researchers' resistance in adopting new innovations
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Mycoplasma Testing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Mycoplasma Testing Market, by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • 5.3. Assays, Kits, & Reagents
    • 5.3.1. Global Mycoplasma Testing Market, by Assays, Kits, & Reagents, by Region, 2019-2032 (USD Million)
    • 5.3.2. NAT assays, kits, & reagents
      • 5.3.2.1. Global Mycoplasma Testing Market, by NAT assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.3. ELISA assays, kits, & reagents
      • 5.3.3.1. Global Mycoplasma Testing Market, by ELISA assays, kits, & reagents, by Region, 2019-2032 (USD Million)
    • 5.3.4. Elimination Kits
      • 5.3.4.1. Global Mycoplasma Testing Market, by Elimination Kits, by Region, 2019-2032 (USD Million)
    • 5.3.5. Stains
      • 5.3.5.1. Global Mycoplasma Testing Market, by Stains, by Region, 2019-2032 (USD Million)
    • 5.3.6. Other assays, kits, & reagents
      • 5.3.6.1. Global Mycoplasma Testing Market, by Other assays, kits, & reagents, by Region, 2019-2032 (USD Million)
  • 5.4. Instruments
    • 5.4.1. Global Mycoplasma Testing Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 5.5. Services
    • 5.5.1. Global Mycoplasma Testing Market, by Services, by Region, 2019-2032 (USD Million)

6. Global Mycoplasma Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • 6.3. Cell line testing
    • 6.3.1. Global Mycoplasma Testing Market, by Cell line testing, by Region, 2019-2032 (USD Million)
  • 6.4. Virus Testing
    • 6.4.1. Global Mycoplasma Testing Market, by Virus Testing, by Region, 2019-2032 (USD Million)
  • 6.5. End-of-Production cell testing
    • 6.5.1. Global Mycoplasma Testing Market, by End-of-Production cell testing, by Region, 2019-2032 (USD Million)

7. Global Mycoplasma Testing Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 7.3. NAT
    • 7.3.1. Global Mycoplasma Testing Market, by NAT, by Region, 2019-2032 (USD Million)
  • 7.4. ELISA
    • 7.4.1. Global Mycoplasma Testing Market, by ELISA, by Region, 2019-2032 (USD Million)
  • 7.5. Staining
    • 7.5.1. Global Mycoplasma Testing Market, by Staining, by Region, 2019-2032 (USD Million)
  • 7.6. Other technique
    • 7.6.1. Global Mycoplasma Testing Market, by Other technique, by Region, 2019-2032 (USD Million)

8. Global Mycoplasma Testing Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Mycoplasma Testing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Cell Banks & Laboratories
    • 8.4.1. Global Mycoplasma Testing Market, by Cell Banks & Laboratories, by Region, 2019-2032 (USD Million)
  • 8.5. Contract Research Organizations
    • 8.5.1. Global Mycoplasma Testing Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.6. Academic Research Institutes
    • 8.6.1. Global Mycoplasma Testing Market, by Academic Research Institutes, by Region, 2019-2032 (USD Million)

9. Global Mycoplasma Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Mycoplasma Testing Market - North America
    • 9.3.1. North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.3.2. North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.3.4. North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.5. Mycoplasma Testing Market - U.S.
      • 9.3.5.1. U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.3.6. Mycoplasma Testing Market - Canada
      • 9.3.6.1. Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.4. Mycoplasma Testing Market - Europe
    • 9.4.1. Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.4.2. Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.4.4. Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.5. Mycoplasma Testing Market - UK
      • 9.4.5.1. UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.6. Mycoplasma Testing Market - France
      • 9.4.6.1. France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.6.2. France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.6.4. France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.7. Mycoplasma Testing Market - Germany
      • 9.4.7.1. Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.8. Mycoplasma Testing Market - Italy
      • 9.4.8.1. Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.9. Mycoplasma Testing Market - Spain
      • 9.4.9.1. Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.10. Mycoplasma Testing Market - Netherlands
      • 9.4.10.1. Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.4.11. Mycoplasma Testing Market - Russia
      • 9.4.11.1. Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.5. Mycoplasma Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.5. Mycoplasma Testing Market - China
      • 9.5.5.1. China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.5.4. China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.6. Mycoplasma Testing Market - India
      • 9.5.6.1. India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.6.4. India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.7. Mycoplasma Testing Market - Japan
      • 9.5.7.1. Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.8. Mycoplasma Testing Market - Malaysia
      • 9.5.8.1. Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.9. Mycoplasma Testing Market - Indonesia
      • 9.5.9.1. Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.5.10. Mycoplasma Testing Market - South Korea
      • 9.5.10.1. South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.6. Mycoplasma Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.5. Mycoplasma Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.6. Mycoplasma Testing Market - South Africa
      • 9.6.6.1. South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.7. Mycoplasma Testing Market - Israel
      • 9.6.7.1. Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.6.8. Mycoplasma Testing Market - UAE
      • 9.6.8.1. UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • 9.7. Mycoplasma Testing Market - Latin America
    • 9.7.1. Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.5. Mycoplasma Testing Market - Mexico
      • 9.7.5.1. Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.6. Mycoplasma Testing Market - Brazil
      • 9.7.6.1. Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
    • 9.7.7. Mycoplasma Testing Market - Argentina
      • 9.7.7.1. Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Agilent Technologies (US)
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. American Type Culture Collection (US)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Biological Industries Israel Beit Haemek Ltd. (Israel)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bionique Testing Laboratories, Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Biotools B & M Labs, S.A. (Spain)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Charles River Laboratories International, Inc. (US)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Creative Bioarray (US)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eurofins Scientific (Luxembourg)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. GeneCopoeia, Inc. (US)
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GenBio (Canada)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. InvivoGen (US)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lonza Group Ltd. (Switzerland)
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck KGaA (Germany)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Meridian Bioscience, Inc. (US)
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Minerva Biolabs GmbH (Germany)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Mycoplasma Testing Market, by Product & Service, by Region, 2019-2032 (USD Million)
  • Table 2 Global Mycoplasma Testing Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 3 Global Mycoplasma Testing Market, by Technique, by Region, 2019-2032 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Mycoplasma Testing Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 7 North America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 8 North America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 9 North America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 10 U.S.: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 11 U.S.: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 12 U.S.: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 13 U.S.: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 14 Canada: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 15 Canada: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 16 Canada: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 17 Canada: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 18 Europe: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 19 Europe: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 20 Europe: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 21 Europe: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 22 Germany: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 23 Germany: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 24 Germany: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 25 Germany: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 26 France: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 27 France: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 28 France: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 29 France: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 30 UK: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 31 UK: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 32 UK: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 33 UK: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 34 Italy: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 35 Italy: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 36 Italy: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 37 Italy: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 38 Netherlands: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 39 Netherlands: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 40 Netherlands: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 41 Netherlands: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 42 Spain: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 43 Spain: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 44 Spain: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 45 Spain: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 46 Russia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 47 Russia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 48 Russia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 49 Russia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 54 China: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 55 China: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 56 China: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 57 China: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 58 Japan: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 59 Japan: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 60 Japan: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 61 Japan: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 62 India: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 63 India: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 64 India: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 65 India: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 66 Indonesia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 67 Indonesia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 68 Indonesia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 69 Indonesia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 70 Malaysia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 71 Malaysia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 72 Malaysia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 73 Malaysia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 74 South Korea: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 75 South Korea: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 76 South Korea: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 77 South Korea: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 78 Latin America: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 79 Latin America: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 80 Latin America: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 81 Latin America: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 82 Brazil: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 83 Brazil: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 84 Brazil: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 85 Brazil: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 86 Mexico: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 87 Mexico: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 88 Mexico: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 89 Mexico: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 90 Argentina: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 91 Argentina: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 92 Argentina: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 93 Argentina: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 98 UAE: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 99 UAE: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 100 UAE: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 101 UAE: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 106 South Africa: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 107 South Africa: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 108 South Africa: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 109 South Africa: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)
  • Table 110 Israel: Mycoplasma Testing Market, by Product & Service, 2019-2032 (USD Million)
  • Table 111 Israel: Mycoplasma Testing Market, by Application, 2019-2032 (USD Million)
  • Table 112 Israel: Mycoplasma Testing Market, by Technique, 2019-2032 (USD Million)
  • Table 113 Israel: Mycoplasma Testing Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Mycoplasma Testing Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product & Service
  • Figure 7. Global Mycoplasma Testing Market, by Product & Service, 2021 & 2030 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Mycoplasma Testing Market, by End User, 2021 & 2030 (USD Million)
  • Figure 10. Market by Application
  • Figure 11. Global Mycoplasma Testing Market, by Application, 2021 & 2030 (USD Million)
  • Figure 12. Market by Technique
  • Figure 13. Global Mycoplasma Testing Market, by Technique, 2021 & 2030 (USD Million)